Health
Studies show up to 62% of Lyme patients suffer persistent symptoms—crippling fatigue, neurological issues, and pain—years after antibiotic treatment. The CDC acknowledges Post-Treatment Lyme Disease Syndrome (PTLDS), yet the medical establishment downplays its impact. Ignoring these patients is irresponsible—Lyme disease is lifelong for many.
Studies show over 90% of patients recover fully with antibiotics. Persistent symptoms affect only a small subset, often due to unrelated conditions. Chronic Lyme is a myth, not a medical reality.
Lyme disease is not a lifelong ailment—this claim is medically unfounded. The Infectious Diseases Society of America (IDSA) confirms that over 90% of Lyme cases are effectively cured with a 2-4 week antibiotic regimen (CDC, 2023). Persistent symptoms in rare cases, known as Post-Treatment Lyme Disease Syndrome (PTLDS), are not due to active infection but immune response. Promoting the myth of lifelong Lyme only fuels pseudoscience and harms patient care with unnecessary, dangerous treatments.
The IDSA’s claim ignores reality—up to 36% of Lyme patients suffer persistent symptoms despite treatment (Aucott et al., 2013). Research shows live Borrelia bacteria in treated patients (Embers et al., 2012). Denying chronic Lyme delays care and worsens patient suffering.